Gabriel A Carpio-Bracho, MD
Family Practice · Fresno
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 13 years
- Graduated 2013
Offices
2 locations · Carpio-Bracho and Gutierrez, A Medical Corporation · Camarena Health
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Carpio-Bracho’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A141844 · Current
Licensed to practise in California · since 2016 · expires 2028-04-30 · Autonomous University of Guadalajara Faculty of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Illinois 125063987Temporary Medical Permit · since 2013 · expires 2016-06-30Specialty on the licence: Family MedicineCancelledNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Family Medicine - Family Medicine
- American Board of Family Medicine - Sports Medicine
Medicaid work
$250,758 in 2024
Medicaid paid $250,758 for 17,691 billed services this clinician did in 2024, up to 181 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 1,786 | $250,393 |
| Short return visit (20+ min) | 3,333 | $366 |
| TOBACCO NON-USER | 1,884 | $0 |
| Medication list documented in medical record (COA) | 400 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 400 | $0 |
| BODY MASS INDEX DOCD | 2,639 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 2,115 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 246 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 1,990 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 390 | $0 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 44 | $0 |
| Screening for depression performed (DEM) | 1,342 | $0 |
| 2024 | 17,691 | 17 | 181 | $250,758 |
| 2023 | 6,544 | 15 | 169 | $92,684 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 664 | $92,635 |
| Short return visit (20+ min) | 1,193 | $45 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 87 | $4 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) | 224 | $0 |
| TOBACCO NON-USER | 547 | $0 |
| Medication list documented in medical record (COA) | 563 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 563 | $0 |
| BODY MASS INDEX DOCD | 796 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 627 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 23 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 540 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 54 | $0 |
Drugs they prescribed that Part D paid
$2,963
Pharmacies billed $2,963 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 92) in 2024. At or below the middle of the specialty; the typical family practice clinician is at 2%.
82 generic and fewer than 11 brand-name prescriptions · $2,963 in drug cost · 13 antibiotic prescriptions to 12 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Naproxen | 17 | $53 | $3 |
Year by year
| 2024 | 92 | 75 | 0% (0) | None | $2,963 |
| 2023 | 49 | 38 | None | None | $1,117 |
| 2022 | 52 | 19 | 0% (0) | None | $3,007 |
| 2021 | 334 | 66 | None | None | $23,800 |
| 2020 | 372 | 71 | None | 6% | $19,006 |
| 2019 | 392 | 78 | None | None | $18,214 |
| 2018 | 108 | 38 | None | 12% | $3,390 |
| 2017 | 61 | 32 | None | None | $4,230 |
| 2016 | 439 | 46 | None | 24% | $45,471 |
| 2015 | 349 | 47 | None | 21% | $25,387 |
| 2014 | 62 | 14 | None | 18% | $1,663 |
| 2013 | 19 | None | 0% (0) | None | $723 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2021: 7 drugs
| Rosuvastatin | 22 | $2,011 | $91 |
| Atorvastatin | 38 | $533 | $14 |
| Amlodipine Besylate | 28 | $377 | $13 |
| Lisinopril | 18 | $218 | $12 |
| Simvastatin | 14 | $69 | $5 |
| Losartan | 12 | $52 | $4 |
| Hydrochlorothiazide | 14 | $52 | $4 |
2020: 7 drugs
| Rosuvastatin | 15 | $2,069 | $138 |
| Atorvastatin | 34 | $397 | $12 |
| Amlodipine Besylate | 39 | $347 | $9 |
| Simvastatin | 18 | $189 | $10 |
| Losartan | 11 | $181 | $16 |
| Meloxicam | 23 | $81 | $4 |
| Naproxen | 18 | $80 | $4 |
2019: 8 drugs
| Rosuvastatin | 15 | $2,297 | $153 |
| Atorvastatin | 29 | $515 | $18 |
| Levothyroxine | 12 | $420 | $35 |
| Losartan | 20 | $255 | $13 |
| Lisinopril | 14 | $141 | $10 |
| Amlodipine Besylate | 19 | $135 | $7 |
| Naproxen | 21 | $83 | $4 |
| Meloxicam | 17 | $62 | $4 |
2016: 12 drugs
| Lantus | 17 | $5,417 | $319 |
| Crestor | 13 | $5,241 | $403 |
| Humalog | 16 | $4,030 | $252 |
| Tamsulosin | 15 | $1,529 | $102 |
| Celecoxib | 11 | $1,200 | $109 |
| Metoprolol | 19 | $709 | $37 |
| Atorvastatin | 33 | $562 | $17 |
| Clopidogrel | 19 | $331 | $17 |
| Metformin | 35 | $312 | $9 |
| Lisinopril | 32 | $229 | $7 |
| Omeprazole | 13 | $141 | $11 |
| Sertraline | 11 | $75 | $7 |
2015: 11 drugs
| Crestor | 13 | $5,512 | $424 |
| Celecoxib | 11 | $1,484 | $135 |
| Tamsulosin | 14 | $1,085 | $78 |
| Atorvastatin | 20 | $287 | $14 |
| Sertraline | 18 | $215 | $12 |
| Allopurinol | 13 | $178 | $14 |
| Lisinopril-Hydrochlorothiazide | 17 | $161 | $9 |
| Metformin | 19 | $146 | $8 |
| Omeprazole | 12 | $116 | $10 |
| Lisinopril | 17 | $88 | $5 |
| Ibuprofen | 13 | $81 | $6 |
2014: 1 drug
| Lisinopril-Hydrochlorothiazide | 11 | $34 | $3 |
Money from drug and device companies
$29 in 2020
| 2020 | 1 | 1 | None | $29 |
| 2019 | 2 | 2 | None | $36 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Welch Allyn | Spot Vision Screener | $29 | 1 payment
|
See the published payment
| Welch Allyn | Gift · 2020-12-02 | Spot Vision Screener | $29 |
See earlier years (2019)
2019: $36
| Medtronic USA | Intellis | $23 | 1 payment
|
| Lilly USA | Emgality | $13 | 1 payment
|
Professional record
- NPI
- 1700226669
- Licence
- CA A141844, IL 125.063987California A141844: Current · expires 2028-04-30Illinois 125063987: Cancelled
- Group
- Carpio-Bracho and Gutierrez, A Medical Corporation · Camarena Health
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207QS0010X (207QS0010X); Family medicine (207Q00000X); Student in a training program (390200000X)
- Mailing address
- 3636 N 1st St Ste 160, Fresno, CA, 93726
- NPI first listed
- 2013-06-25
- NPI last updated
- 2022-07-06
- NPI record certified
- 2022-07-06
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1431 N Western Ave, Chicago, IL, 60622 · 4900 Barranca Pkwy Ste 103, Irvine, CA, 92604